Doximity (NYSE: DOCS)
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-08 | ||||||
REV |
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.100 | 0.140 | 0.0400 | ||||
REV | 89.300M | 90.639M | 1.339M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Doximity (NYSE: DOCS) through any online brokerage.
Other companies in Doximity’s space includes: Change Healthcare (NASDAQ:CHNG), MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX) and Pear Therapeutics (NASDAQ:PEAR).
The latest price target for Doximity (NYSE: DOCS) was reported by Goldman Sachs on Monday, August 8, 2022. The analyst firm set a price target for 46.00 expecting DOCS to rise to within 12 months (a possible 15.27% upside). 30 analyst firms have reported ratings in the last year.
The stock price for Doximity (NYSE: DOCS) is $39.905 last updated August 10, 2022, 7:59 PM UTC.
There are no upcoming dividends for Doximity.
Doximity’s Q2 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Doximity.
Doximity is in the Health Care sector and Health Care Technology industry. They are listed on the NYSE.